SORA

Advancing, promoting and sharing knowledge of health through excellence in teaching, clinical practice and research into the prevention and treatment of illness

Clinical characteristics and prognosis of patients with microvascular angina: an international and prospective cohort study by the Coronary Vasomotor Disorders International Study (COVADIS) Group

Shimokawa, H; Suda, A; Takahashi, J; Berry, C; Camici, PG; Crea, F; Escaned, J; Ford, T; Yii, E; Kaski, JC; et al. Shimokawa, H; Suda, A; Takahashi, J; Berry, C; Camici, PG; Crea, F; Escaned, J; Ford, T; Yii, E; Kaski, JC; Kiyooka, T; Mehta, PK; Ong, P; Ozaki, Y; Pepine, C; Rimoldi, O; Safdar, B; Sechtem, U; Tsujita, K; Yasuda, S; Beltrame, JF; Merz, CNB (2021) Clinical characteristics and prognosis of patients with microvascular angina: an international and prospective cohort study by the Coronary Vasomotor Disorders International Study (COVADIS) Group. Eur Heart J, 42 (44). pp. 4592-4600. ISSN 1522-9645 https://doi.org/10.1093/eurheartj/ehab282
SGUL Authors: Kaski, Juan Carlos

[img]
Preview
PDF Published Version
Available under License Creative Commons Attribution Non-commercial.

Download (1MB) | Preview
[img]
Preview
PDF Accepted Version
Available under License Creative Commons Attribution Non-commercial.

Download (2MB) | Preview

Abstract

Aims To provide multi-national, multi-ethnic data on the clinical characteristics and prognosis of patients with microvascular angina (MVA). Methods and results The Coronary Vasomotor Disorders International Study Group proposed the diagnostic criteria for MVA. We prospectively evaluated the clinical characteristics of patients according to these criteria and their prognosis. The primary endpoint was the composite of major cardiovascular events (MACE), verified by institutional investigators, which included cardiovascular death, non-fatal myocardial infarction, non-fatal stroke, and hospitalization due to heart failure or unstable angina. During the period from 1 July 2015 to 31 December 2018, 686 patients with MVA were registered from 14 institutes in 7 countries from 4 continents. Among them, 64% were female and the main ethnic groups were Caucasians (61%) and Asians (29%). During follow-up of a median of 398 days (IQR 365–744), 78 MACE occurred (6.4% in men vs. 8.6% in women, P = 0.19). Multivariable Cox proportional hazard analysis disclosed that hypertension and previous history of coronary artery disease (CAD), including acute coronary syndrome and stable angina pectoris, were independent predictors of MACE. There was no sex or ethnic difference in prognosis, although women had lower Seattle Angina Questionnaire scores than men (P < 0.05). Conclusions This first international study provides novel evidence that MVA is an important health problem regardless of sex or ethnicity that a diagnosis of MVA portends a substantial risk for MACE associated with hypertension and previous history of CAD, and that women have a lower quality of life than men despite the comparable prognosis.

Item Type: Article
Additional Information: © The Author(s) 2021. Published by Oxford University Press on behalf of the European Society of Cardiology. This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
Keywords: Coronary microvascular dysfunction, Microvascular angina, Prognosis, 1102 Cardiorespiratory Medicine and Haematology, Cardiovascular System & Hematology
SGUL Research Institute / Research Centre: Academic Structure > Molecular and Clinical Sciences Research Institute (MCS)
Journal or Publication Title: Eur Heart J
ISSN: 1522-9645
Language: eng
Dates:
DateEvent
21 November 2021Published
26 May 2021Published Online
23 April 2021Accepted
Publisher License: Creative Commons: Attribution-Noncommercial 4.0
Projects:
Project IDFunderFunder ID
UNSPECIFIEDJapan Heart FoundationUNSPECIFIED
PG/17/2532884British Heart Foundationhttp://dx.doi.org/10.13039/501100000274
RE/18/6134217British Heart Foundationhttp://dx.doi.org/10.13039/501100000274
N01-HV-68161National Heart, Lung, and Blood Institutehttp://dx.doi.org/10.13039/100000050
N01-HV-68162National Heart, Lung, and Blood Institutehttp://dx.doi.org/10.13039/100000050
N01-HV-68163National Heart, Lung, and Blood Institutehttp://dx.doi.org/10.13039/100000050
N01-HV-68164National Heart, Lung, and Blood Institutehttp://dx.doi.org/10.13039/100000050
U0164829National Institute on Aginghttp://dx.doi.org/10.13039/100000049
U01 HL649141National Institute on Aginghttp://dx.doi.org/10.13039/100000049
U01 HL649241National Institute on Aginghttp://dx.doi.org/10.13039/100000049
K23HL105787National Institute on Aginghttp://dx.doi.org/10.13039/100000049
T32HL69751National Institute on Aginghttp://dx.doi.org/10.13039/100000049
R01 HL090957National Institute on Aginghttp://dx.doi.org/10.13039/100000049
1R03AG032631National Institute on Aginghttp://dx.doi.org/10.13039/100000049
MO1-RR00425National Center for Research Resourceshttp://dx.doi.org/10.13039/100000097
UL1TR000124National Center for Advancing Translational Scienceshttp://dx.doi.org/10.13039/100006108
UL1TR000064National Center for Advancing Translational Scienceshttp://dx.doi.org/10.13039/100006108
PubMed ID: 34038937
Go to PubMed abstract
URI: https://openaccess.sgul.ac.uk/id/eprint/113199
Publisher's version: https://doi.org/10.1093/eurheartj/ehab282

Actions (login required)

Edit Item Edit Item